Table 3.
A comparison of different SARS-CoV-2 detection methods.
| Methods | Principle/ target of detection | Limit of detection | Time (h) | Merits |
|
Ref |
|---|---|---|---|---|---|---|
| RT-PCR | RNA template converted into cDNA which is amplified. Specific primer-probe based detection of viral RNA | 95%; 100 copies of RNA per ml of transport media (approx.) | 3–4 h |
|
|
[16,21] |
| RT-LAMP | Based on autocycling strand displacement DNA synthesis. Uses more than two sets of specific primer for detection. | a copy of the RNA template per reaction | 60–90 min |
|
|
[22] |
| NP antigen detection test | Viral antigen (nucleocapsid protein) detection. Point-of-care (PoC) test. |
0.58 copies per μl | 15–30 min |
|
|
[66] |
| Plasmonic biosensor | Use label free probe of biological analytes for detecting molecules (viral particles) at much lower concentration | 0.22 pM of viral particles | Few minutes |
|
|
[41] |
| Bioelectric biosensor | Uses biorecognition element that reacts with target and produce signal proportional to the concentration of the target. | 1 fg/ml | 3 min |
|
|
[44] |
| Microarray based techniques | The target DNA fragments with fluorescent probes bind with probes of DNA chip due to complementarity which is measured using fluorescence emission. | 100% | 10 min |
|
|
[13,50] |
| ELISA | Antibody detection using a specific antigen (enzyme substrate reaction). | 97.8% IgG | 4–6 h |
|
|
[21,54] |
| NGS based platform | Whole genome sequencing | 100% | 1–2 day |
|
|
[55,56] |
| CRISPR-Cas-based detection | Finds a specific bit of DNA inside a cell. | 10 copies per microlitre of viral RNA | 40–60 min | detection within minutes, low cost |
|
[59,61,62] |
| Digital platforms for detection/ tracking | By recording Cough or speech pattern or other physiological manifestations and applying AI | Can be detected symptomatic/ asymptomatic patients accurately | Few minutes | Yet not implemented in larger set up |
|
[[63], [64], [65]] |